A South Dakota law that prevents drug companies from restricting federal drug discounts for hospitals and other providers will remain in effect for now, a judge has decided.
Chicago-based AbbVie Inc., whose products include the wrinkle-remover Botox and the arthritis drug Humira, sued the state earlier this year in the U.S. District Court of South Dakota. The lawsuit challenges the legality of Senate Bill 154, which lawmakers and Gov. Larry Rhoden approved in March. It blocks drugmakers from deciding which pharmacies hospitals can use to access discounted medication.









